Best disease, or vitelliform macular dystrophy, is an inherited eye disorder characterized by its impact on the macula, the central area of the retina crucial for sharp vision. Typically appearing in childhood or early adulthood, it progresses gradually. In Best disease, abnormal lipofuscin deposits gather beneath the macula, causing gradual damage to retinal cells. This leads to symptoms such as central vision loss, blurry vision, and distortion. Genetic mutations, notably in the BEST1 gene, underlie Best disease, with inheritance patterns varying. Presently, there is no cure. Management involves regular vision monitoring, using aids as needed, and genetic counseling. Ongoing research aims to deepen our understanding of the disease and explore potential therapies to safeguard vision in affected individuals.







Title : Why a paediatric orthoptic oncology service matters
Shenika Tailor, University Hospitals of Leicester NHS Trust, United Kingdom
Title : Stereotactic radiotherapy for wet age-related macular degeneration: year 4 results of a randomised, double-masked, sham-controlled trial
Tim Jackson, King’s College London, United Kingdom